Posts in category Top Stories


Could Hospitals Making Generic Assets Impact Teva Pharmaceutical Industries Ltd (ADR) and Endo International plc? Analysts Answer

A NYT article has Wall Street abuzz today with whispers of non-profit hospital groups creating a new generics maker or partnering with third party manufacturers.

Apple Inc. (AAPL) Paying Off $38 Billion Cash Tax Hit Is Good Move for 2018 Backdrop

Guggenheim’s Rob Cihra is more confident than consensus on AAPL, calling for a strong performance in the fiscal year ahead.

Teva Pharmaceutical Industries Ltd (ADR) (TEVA): This Will Not Be the Only Rating Cut to Come

Guggenheim’s Rohit Vanjani reacts to the debt rating downgrade on Teva from the sidelines without shock, having seen the writing on the wall.

Shopify Inc (US) (SHOP): The Bullish Thesis Has Gotten a Boost

By Ophir Gottlieb Spotlight Top Pick Shopify Inc (US) (NYSE:SHOP) had a big run but was up-ended …

Facebook Inc (FB): Don’t Worry- the News Feed Update Will Not Shake the Upward Trajectory of Advertising Revenue Gains

One of Wall Street’s best analysts explains why the changes that have upset FB investors today will ultimately prove to be valuable longer-term.

Roku Inc (ROKU) Has a Bumpy Ride Ahead

By Ophir Gottlieb Roku Inc (NASDAQ:ROKU) is a Spotlight Top Pick, one of the riskiest we have in …

Two of Wall Street’s Top Analysts Are Bulls on These Tech Giants: Apple Inc. (AAPL), Amazon.com, Inc. (AMZN)

Apple in strong standing for upside in its FQ1 print; Amazon showcases meaningful prospects to capture U.S. wallet share.

Bitcoin 2018: Tailwinds Should Trump Headwinds, Say Top Analysts

Following a feverish 2017, Bitcoin should continue to rise in 2018 according to Canaccord’s top …

Show More